Teva chairman Moshe Many to step down
Mr. Many has served as Vice Chairman of the Board of Directors of Teva since March 2010, having served as a director of Teva since 1987.
He has served as president of the Ashkelon Academic College from January 2002 until July 2012 and was previously President of Tel Aviv University.
He served as Chief of Urology from 1976 until 1987 and as Chairman of Surgery from 1983 until 1987 at Sheba Medical Center.
Mr. Many serves as Chairman of the Board of Real Imaging Ltd. and as a director of BiondVax Pharmaceuticals Ltd.
He also served as a director of Rosetta Genomics from 2002 to 2011.
In January 2010, he received the Israel Ministry of Health Lifetime Achievement Award in recognition of his outstanding and unique contributions to the promotion and support of health matters in Israel.
Mr. Many received his M.D. degree from Geneva University and his Ph.D. in renal physiology from Tufts University. ■
What to read next
LATEST MOVES FROM Israel
- Teva appoints Kåre Schultz as CEO
- Immune Pharma appoints Tony Fiorino as COO
- Enzymotec appoints Dror Israel as CFO
- Intec Pharma appoints Jeffrey A. Meckler as CEO
- Foamix Pharmaceuticals names David Domzalski as CEO
More inside POST